Background: Gender differences among patients with coronary artery disease vary from study to study. In one of the largest studies, the Japanese Coronary Artery Disease (JCAD) Study, gender differences in patients were investigated. Methods and Results: Consecutive patients diagnosed with stenosis 75% or more in at least one branch of the coronary arteries were enrolled in the study. The endpoint is a composite of all-cause death and cardiovascular events. Data were collected over the internet. Out of 15,628 patients screened, 13,812 of them met the inclusion criteria and were followed up for a mean period of 2.7 years. The event rate was 62.8 per 1,000 patients-year, all-cause death 17.3 and total cardiac events 47.4. The incident rate of unstable angina was higher in females (27.1) than males (21.8) (P=0.0363). The incidence of all-cause death was lower in females than males (16.9 and 17.8, respectively; P=0.0148). Other than gender, hypertension and number of vessel disease contribute to the event of unstable angina, and age, family history, obesity, impaired fasting glycemia, hyperlipidemia, congestive heart failure and number of vessel disease contribute to the all-cause death. Conclusions: Gender is an independent contributing factor of unstable angina and of all-cause death. (Circ J 2009; 73: 912 -917) 
oronary and cerebrovascular diseases are the leading causes of death in Japan. 1 The incidence of coronary artery diseases (CADs) and the prognosis are known to be different between men and women. 1, 2 The Japanese Coronary Artery Disease (JCAD) Study 3 is one of the largest cohort studies conducted to date in Japan, in which the diagnosis of CAD was confirmed in more than 13,000 of the enrolled patients with coronary angiography (CAG). The aim of the present study is to assess gender difference with regard to prognosis and to evaluate the contributing factors using this large scale database.
Methods

Investigations
The complete protocol of the present study with the purpose, study design, criteria for eligibility and exclusion of patients, clinical measures, events and statistical analyses has been published elsewhere. 4 Briefly, the patients underwent CAG for various reasons, such as old and acute myocardial infarction (MI), stable and unstable angina, chronic heart failure and clinical demand to perform the procedure. All CAG was performed after written consent was given, except in emergency cases in which oral agreement was obtained. All consecutive patients diagnosed as having 75% or higher stenosis according to the American Heart Association (AHA) classification in at least one branch of the coronary arteries by cardiac catheterization were registered in the study. Data including background information, risk factors, clinical management, and medication were collected over the internet. When follow-up data of more than 6 months could be obtained or when a cerebro-and cardiovascular event occurred, including death, within 6 months of enrollment, the participants were included in the final analysis. The patients were followed up for 3 years. The endpoint used in this report is a composite of all-cause death and cardiovascular events, defined as the occurrence of fatal and non-fatal MI, fatal and non-fatal stroke, other cardiovascular events and death of any cause.
Clinical events to be registered in the database were defined as follows: all-cause deaths including cardiac, cerebral, vascular and other deaths and cerebral, cardiac and vascular events. Cerebro-vascular accidents (CVAs) included cerebral hemorrhage, cerebral infarction and transient ischemic attack (TIA (CHF), coronary bypass graft surgery (CABG), resuscitated cardiac arrest and cardiopulmonary arrest on arrival (CPAOA). Aortic dissection and rupture of aortic aneurysm were classified as vascular events.
Statistical Analysis
Continuous variables are expressed as mean ± SD (median), and categorical variables are expressed as percentages. Mean values for age, left ventricular ejection fraction (LVEF), lipid concentration, HbA1c, blood pressure, height, weight, body mass index (BMI), cigarettes, uric acid, Lp(a), C-reactive protein (CRP), and fibrinogen were tested with the Wilcoxon test, and the prevalence of baseline characteristics were tested with the chi-square test for comparison between men and women. Relative risks and the 95% confidence intervals were calculated using the Cox proportional hazards model with adjustment for baseline characteristics such as age, obesity, smoking, family history, past history of MI, angina pectoris (AP) and CHF, coronary interventions, CHF, LVEF, number of coronary vessel disease, left main trunk disease, impaired fasting glycemia (IFG) including diabetes mellitus, lipid profile, hypertension and others ( Table 1) . A P-value <0.05 was considered significant.
Ethical Considerations
The protocol of the current study was approved by the Central Institutional Review Board in the University of Tokyo.
Results
Of the recruited 15,628 individuals, 13,748 CAD patients satisfied the criteria for eligibility. The patients consisted of 3,172 females and 10,576 males ( Table 1 ). The follow-up rate was 83.5% and the mean follow-up period was 2.7 years. Females were older than males in average (68.8±9.1 years old in females, 64.5±9.8 years old in males). Nearly 50% of the patients had a history of MI; 58.6% in males but 46.8% in females. AP was present in 57.5% in females, and 48.1% in males. With regard to risk factors, 54.6% of the patients had hyperlipidemia (62.7% in females, 52.2% in males), and 57.6% had hypertension (64.5% in females, 55.5% in males). Patients with IFG were 40.3% (43.3% in females, 39.5% in males). More than 65% of the patients bore multiple risk factors of life style-related diseases (smoking, BMI ≥25, hypertension, IFG, hyperlipidemia, regular alcohol consumption); 35.9% had 2 risk factors, 23.5% had 3 and 5.9% had 4 risk factors.
The Incident Rate of Events
The incident rates of events as expressed in events per 1,000 patient-years are shown in Table 2 . The incidence Table 2 . Table 3 shows clinical factors contributing to unstable angina and all-cause of death. Female gender, as well as hypertension and number of vessel disease, increase the risk of unstable AP. In all-cause death male gender as well as age, CHF, IFG and number of vessel disease contributed to increase hazard, whereas presence of hyperlipidemia, obesity and family history decrease hazard. Table 4 shows contributing factors in various clinical events in female and in male. Smoking plays an important role in acute MI and all-cause death, but alcohol consump-tion is beneficial in the latter in female. Age is contributing to various events except acute MI in both genders and unstable AP in female. A history of CHF plays an important role in cardiac events and cardiovascular death except unstable AP in both genders. Ordinary coronary risk factors (hypertension, hyperlipidemia, IFG) are also closely correlated with various events in this study group. Number of coronary vessel disease is associated with cardio-and cerebro-vascular events, but not in acute MI.
Discussion
Our study is unique to assess gender difference with regard to prognosis and to evaluate the contributing factors using a large number of patients with angiographically confirmed coronary atherosclerosis. Gender is an independent contributing factor in prognosis of unstable angina (worse in females than males) and in all-cause mortality (better in females than males) of this large scale cohort in JCAD patients. Hypertension and number of vessel disease also contribute to the former, and age, CHF, number of vessel disease, IFG, hyperlipidemia, obesity, and family history contribute to the latter.
The incident rate of MI in this study was 7.56 per 1,000 patients-year, which is considerably higher than the numbers in the general population (0.524-1.25 per 1,000 patients- year 5,6 ) or in the primary prevention cohort of Japanese with hyperlipidemia treated with simvastatin in the J-LIT study, 7 which was 0.86 per 1,000 patients-year. However, the prevalence rate of IFG, hyperlipidemia and hypertension at the time of registration in this study was approximately 40%, 55% and 58%, respectively, which is approximately double or triple the values in the administrative report. These high incident rates of risk factors and of MI are reasonably attributed to the fact that participants in this study had significant coronary atherosclerosis confirmed with CAG. The present report addressed the gender difference in many clinical profiles such as age, congestive heart failure, IFG, hyperlipidemia, hypertension and fibrinogen, all of which were more frequent or higher in value in females, whereas height, weight, BMI, smoking, history of coronary heart disease, coronary intervention, uric acid and CRP concentration, all of which were more common or higher in males ( Table 1 ). These findings are in agreement partly with observations reported elsewhere, in which women presenting with the first clinical symptom are generally older than men [8] [9] [10] [11] [12] and have significant higher rates of diabetes mellitus, hypertension and previous CHF. 13 Men experience worse outcomes than women, with an increased risk of cardiac events 14 but the incidence of unstable angina in the current study was higher in females than males. Contributing factors for unstable angina in this study are hypertension and number of vessel disease other than gender ( Table 3 ). Percentage of hypertension was significantly higher in females ( Table 1) . The higher incidence rate of unstable angina in females is somewhat surprising but similar results were reported in patients of CAVEAT-I study. 15 The reasons are speculative. The variability in results probably reflects the mixed populations studied, with differing percentages of patients with non-Q-wave and Qwave infarction. A smaller percentage of women than men had infarction with ST elevation. 13 Furthermore, parameters used are varied among the studies, and the weights of parameters are influenced by the covariate used. 16 Most studies report higher mortality after unstable angina 14 or MI [17] [18] [19] [20] [21] [22] [23] in women compared to men. This effect is primarily seen in younger women and progressively declines with age, with equivalent outcomes in the elderly. 19 The worse outcome in women is largely related to increased age and greater comorbidity, 9, 18, 20, 22 such as diabetes mellitus and hypertension, 17, 24 comparable with our results. Heart failure is also more common in females than males. 25, 26 This seems to be due at least in part to a greater frequency of diastolic dysfunction, 26 which might relate with hypertension. Another risk factor for heart failure in women is diabetes mellitus. 27 However, women were less likely to have clinically significant coronary artery stenosis. The latter finding might explain a similar 28 or better outcome than men, 13, 14, 29 and after multivariate analysis, women had a trend toward a lower risk of death. A later analysis from Finland suggested that the prognosis might not be different in women. 30 The outcome of JCAD study showed lower all-cause mortality in females than males, and cerebro/cardiovascular death accounted for more than a half of deaths in both sexes.
Current reports provide important insight into our understanding of the impact of gender on the natural history of atherosclerosis, but it remains uncertain whether the pathophysiology of CAD differs in women. 25, 31, 32 The traditional view has proposed that clinical events typically begin later in life in women, which is attributed to the protective influ-ence of endogenous estrogen. Other explanations about differences between the sexes might relate to differences in thrombotic and fibrinolytic activity [33] [34] [35] [36] or differences in the extent of collateral blood flow. [37] [38] [39] Reduced collateral blood flow in women might account for the higher rate of complications when total coronary occlusion (infarction with ST elevation) occurs. 39 Alternative mechanisms underlying gene by sex interaction has been suggested to be considered. 40 Finally, we have to keep in mind that women are typically under-represented in clinical trials and less likely to be investigated, and are not referred as often as men for appropriate diagnostic and/or therapeutic procedures, despite similar clinical conditions. 41, 42 
Study Limitations
This study is quite unique in that it enrolled a large number of patients with angiographically-confirmed coronary atherosclerosis. However, this is a subanalysis of the JCAD study, and further studies are necessary to determine which factors account for the significant differences in outcome between both genders.
In the current study of subjects with angiographically evident CAD, women had less coronary atheroma. It remains to be established whether there are any gender-specific differences in the pathophysiology of atherosclerosis and which factors account for the significant differences in outcome.
